Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748
The authors wish to make the following correction to this paper [...] View Full-Text
Kojima, M.; Sugimoto, K.; Tanaka, M.; Endo, Y.; Kato, H.; Honda, T.; Furukawa, S.; Nishiyama, H.; Watanabe, T.; Soeda, S.; Fujimori, K.; Chiba, H. Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. Cancers 2021, 13, 971. https://doi.org/10.3390/cancers13050971
Kojima M, Sugimoto K, Tanaka M, Endo Y, Kato H, Honda T, Furukawa S, Nishiyama H, Watanabe T, Soeda S, Fujimori K, Chiba H. Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. Cancers. 2021; 13(5):971. https://doi.org/10.3390/cancers13050971
Chicago/Turabian StyleKojima, Manabu; Sugimoto, Kotaro; Tanaka, Mizuko; Endo, Yuta; Kato, Hitomi; Honda, Tsuyoshi; Furukawa, Shigenori; Nishiyama, Hiroshi; Watanabe, Takafumi; Soeda, Shu; Fujimori, Keiya; Chiba, Hideki. 2021. "Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748" Cancers 13, no. 5: 971. https://doi.org/10.3390/cancers13050971